Important pharmacovigilance information: serious cases of overdose reported in infants and children with Perfalgan 10mg/ml solution for children

Hdl Handle:
http://hdl.handle.net/10147/109833
Title:
Important pharmacovigilance information: serious cases of overdose reported in infants and children with Perfalgan 10mg/ml solution for children
Authors:
Bristol-Myers-Squibb Pharmaceuticals
Publisher:
Irish Medicines Board (IMB)
Issue Date:
May-2010
URI:
http://hdl.handle.net/10147/109833
Item Type:
Technical Report
Language:
en
Keywords:
DRUG; MEDICINES; REGULATION

Full metadata record

DC FieldValue Language
dc.contributor.authorBristol-Myers-Squibb Pharmaceuticalsen
dc.date.accessioned2010-08-18T10:14:45Z-
dc.date.available2010-08-18T10:14:45Z-
dc.date.issued2010-05-
dc.identifier.urihttp://hdl.handle.net/10147/109833-
dc.language.isoenen
dc.publisherIrish Medicines Board (IMB)en
dc.subjectDRUGen
dc.subjectMEDICINESen
dc.subjectREGULATIONen
dc.titleImportant pharmacovigilance information: serious cases of overdose reported in infants and children with Perfalgan 10mg/ml solution for childrenen
dc.typeTechnical Reporten
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.